REFERENCES
- Warwick OH, Yendt ER, Olin JS: The clinical features of hypercalcemia associated with malignant disease. Can Med Assoc J 85:719–723, 1961
- Myers WP: Clinical aspects and management of hypercalcemia. Med Clin North Am 40:871, 1956
- Butler ML: Hypercalcemia and leukemia. South Med J 63:591–592, 1970
- Kronfield SJ, Reynolds TB: Leukemia and hypercalcemia. N Engl J Med 271:399–401, 1964
- Knisley RE: Hypercalcemia associated with leukemia. Arch Intern Med 118:14–16, 1966
- David NJ, et al: The diagnostic spectrum of hypercalcemia. Am J Med 33:80, 1962
- Green RA: Hypercalcemia and malignant neoplasm. Univ Mich Med Cent J 30:165–166, 1964
- Ballard HS, Marcus AJ: Hypercalcemia in chronic myelogenous leukemia. N Engl J Med 282:663–665, 1970
- Jordan GW: Serum calcium and phosphorus abnormalities in leukemia. Am J Med 41:381, 1966
- Myers WP: Hypercalcemia in neoplastic disease. Arch Surg 80:308–318, 1960
- Suki WN, et al: Acute treatment of hypercalcemia with furoseraide. N Engl J Med 283:836, 1970
- Pickleman JR, et al: Thiazide-induced parathyroid stimulation. Metabolism 18:867–873, 1969
- Koppel MH, et al: Thiazide-induced rise in serum calcium and magnesium in patients on maintenance hemodialysis. Ann Intern Med 72:895, 1970
- Binger C: Toxicity of phosphates, in relation to blood calcium and tetany. J Pharmacol Exp Ther 10:105–120 1917
- Salvesen HA, Hastings AB, Mcintosh JF: Blood changes and clinical symptoms following oral administration of phosphates. J Biol Chem 60:311–326, 1924
- Bulger HA, et al: The functional pathology of hyperparathyroidism. J Clin Invest 9:143, 1930
- Albright F, et al: Studies in parathyroid physiology. III. J Clin Invest 11:411 1932
- Goldsmith RS, Ingbar SH: Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med 274:1–7,1966
- Hebert LA, et al: Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest 45:1886–1894, 1966
- Logan MA: Recent advances in the chemistry of calcification. Physiol Rev 20:522–560, 1940
- McLean FC, Hinrichs MA: The formation and behavior of colloidal calcium phosphate in the blood. Am J Physiol 121:580–588, 1938
- Dent CE: Some problems of hyperparathyroidism. Br Med J 2:1495–1500, 1962
- Gersh I: Histochemical studies on the fate of colloidal calcium phosphate in the rat. Anat Ree 70: 331–346, 1938
- Sherwood LM: Relative importance of parathyroid hormone and thyrocalcitonin in calcium homeostasis. N Engl J Med 278:663–670, 1968
- Yarbro JW, Kennedy BJ, Barnum CP: Mithramycin inhibition of ribonucleic acid synthesis. Cancer Res 26:36–39, 1966
- Baum M: A clinical trial of mithramycin in the treatment of advanced malignant disease. Br J Cancer 22:176–183, 1968
- Kofman S, Eisenstein R: Mithramycin in the treatment of disseminated cancer. Cancer Chemother Rep 32:77–96, 1963
- Chakzmakjian ZH, Bethune JE: Sodium sulfate treatment of hypercalcemia. N Engl J Med 275: 862–869, 1966
- Perlia CP, et al: Mithramycin treatment of hypercalcemia. Cancer 25:389–394, 1970
- Edwards CR, Besser SM: Mithramycin treatment of malignant hypercalcaemia. Br Med J 3:167–168, 1968_
- Parsons V, Baum M, Self M: Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease. Br Med J 1:474–477, 1967
- Singer FR, et al: Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma. N Engl J Med 283:634–636, 1970
- Walser M: Treatment of hypercalcemias. Mod Treat 7:662–674, 1970
- Brown JH, Kennedy BJ: Mithramycin in the treatment of disseminated testicular neoplasms. N Engl J Med 272:111–118, 1965
- Kenny FM, Holliday MA: Hypoparathyroidism, moniliasis, Addison's and Hashimoto's diseases. N Engl J Med 271:708–713, 1964
- Connor TB, et al: Use of cortisone and ACTH in hypercalcemic states. (Abstr) J Clin Endocrinol Metab 16:945, 1956
- Thomas WC Jr, Connor TB, Morgan HG: Some observations on patients with hypercalcemia exemplifying problems in differential diagnosis, especially in hyperparathyroidism. J Lab Clin Med 32:1119, 1958
- Suki WN, et al: Effect of chronic mineralocorticoid administration on calcium excretion in the rat. Am J Physiol 215:71–74, 1968